颈动脉系统粥样斑块与短暂性脑缺血关系研究(4)
[20]薛文俊,胡国芳,黄薇.颈动脉粥样硬化与TIA 的关系研究[J].中国实用神经疾病杂志,2005,8(15):22-23.
[21] Lloyd-Jones D, Adams R J,Brown T M ,et al.Heart Disease and Stroke Statistics-2010 update: a report from the American Heart Association[J].Circulation,2010,121(7):e46-e215.
[22] Mercuri M, Bond M G, Sirtori C R, et al.Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic mediterranean population:the Carotid Atherosclerosis Italian Ultrasound Study[J].The American Journal of Medicine,1996,101(6):627-634.
[23] Nolting P R, Groot E, Zwinderman A H,et al.Regression of carotid and femoral artery intima-media thickness in familial hypercholesterolemia: treatment with simvastatin[J].Archives of Internal Medicine,2003,163(15):1837-1841.
[24] Reid J A,Wolsey C,Lau L L,et a1.The Effects of pravastatin on intima media thickness 0f the carotid in patients with normal cholesterol[J].Eur J Vasc Endowasc Surg,2005,30(5):464-468.
[25]隋志新.他汀类药物治疗颈动脉斑块的临床意义[J].中国医学创新,2012,9(6):43-44.
[26]苏晓广.阿托伐他汀的药理作用及临床应用分析[J]. 中国当代医药,2011,18(27):14-15.
[27]柯博熙,陆蓉,齐玉祥.瑞舒伐他汀治疗缺血性脑卒中患者颈动脉斑块的疗效观察[J].中国现代医生,2011,49(34):61-64.
[28]施仲伟.2006美国心脏病学会年会关于他汀类药物的强化降脂治疗简况[J].中华老年医学杂志,2006,25(4):315-316.
(收稿日期:2013-01-07) (本文编辑:陈丹云), http://www.100md.com(刘书来 董瑞国)
[21] Lloyd-Jones D, Adams R J,Brown T M ,et al.Heart Disease and Stroke Statistics-2010 update: a report from the American Heart Association[J].Circulation,2010,121(7):e46-e215.
[22] Mercuri M, Bond M G, Sirtori C R, et al.Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic mediterranean population:the Carotid Atherosclerosis Italian Ultrasound Study[J].The American Journal of Medicine,1996,101(6):627-634.
[23] Nolting P R, Groot E, Zwinderman A H,et al.Regression of carotid and femoral artery intima-media thickness in familial hypercholesterolemia: treatment with simvastatin[J].Archives of Internal Medicine,2003,163(15):1837-1841.
[24] Reid J A,Wolsey C,Lau L L,et a1.The Effects of pravastatin on intima media thickness 0f the carotid in patients with normal cholesterol[J].Eur J Vasc Endowasc Surg,2005,30(5):464-468.
[25]隋志新.他汀类药物治疗颈动脉斑块的临床意义[J].中国医学创新,2012,9(6):43-44.
[26]苏晓广.阿托伐他汀的药理作用及临床应用分析[J]. 中国当代医药,2011,18(27):14-15.
[27]柯博熙,陆蓉,齐玉祥.瑞舒伐他汀治疗缺血性脑卒中患者颈动脉斑块的疗效观察[J].中国现代医生,2011,49(34):61-64.
[28]施仲伟.2006美国心脏病学会年会关于他汀类药物的强化降脂治疗简况[J].中华老年医学杂志,2006,25(4):315-316.
(收稿日期:2013-01-07) (本文编辑:陈丹云), http://www.100md.com(刘书来 董瑞国)